Fig: Absorption of Dexmeditomidine
The European Union has not yet given it the go-ahead. Patients
undergoing heart and
Vascular surgeries have been the majority of those who have participated
in clinical trials using Dexmeditomidine. It is critical to accurately
identify patients and administer adequate medication in order to avoid
serious hemodynamic damage. Even after 20 minutes of moderate bolus
loading, the heart rate and blood pressure are only slightly lower than
they were before.
The use of Dexmeditomidine during general anesthesia can be beneficial
in a variety of ways, including awake fibre optic intubation, reducing
the amount of hypnotic and opioid medications required, preventing
postoperative pain, nausea, vomiting, and shivering, and improving
postoperative sleep and recovery. Aside from that, the anti-inflammatory
properties of the medication have been found to cause bradycardia in
certain individuals.